semaglutide essence trial Semaglutide-treated participants in the phase 3 (part 1) have greater concordance of non-invasive test improvements compared with placebo Phase 3 ESSENCE trial: Semaglutide

It changes the size and shape of your stomach and small intestine

[25] It provides a more stable, long-term picture of glycemic control, indicating that statistically, the HbA1c number offers more signal and less noise than an instantaneous reading

Fatty liver (also called steatosis) can occur with inflammation that damages liver cells and ultimately cause scarring and cirrhosis, which can lead to liver failure, liver cancer, and death

Patient monitoring and regular follow-ups are crucial when using semaglutide, especially for individuals with acid reflux

We did this because we learned that many people not on GLP-1s eat in a similar fashion, Roque says